Gilead Sciences Inc. (NASDAQ:GILD) on Oct. 10 announced that the U.S. Food and Drug Administration (FDA) has approved Harvoni® (ledipasvir 90 mg/sofosbuvir 400 mg), the first once-daily single tablet regimen for the treatment of chronic hepatitis C genotype 1 infection in adults. Harvoni combines the NS5A inhibitor ledipasvir with the nucleotide analog polymerase inhibitor sofosbuvir, approved under the tradename Sovaldi® in December 2013. Harvoni’s efficacy has been established in patients with chronic hepatitis C virus (HCV) genotype 1 infection, with a treatment duration of eight, 12 or 24 weeks depending on prior treatment history, cirrhosis status and baseline viral load. Gilead Sciences Inc. (NASDAQ:GILD) in last trading activity moved up 0.75% to close at $96.88. Company weekly performance is -8.47% while its quarterly performance stands at 8.62%. Gilead Sciences Inc. (NASDAQ:GILD) is -12.44% away from its 52 week high.The Dow Chemical Company (NYSE:DOW) believes that packaging can be part of the solution to help reduce food waste, as well as conscientious consumer behavior both in the supermarket and at home. As such, in support of this year's World Food Day on October 16, DOW launched its Make It Last campaign to bring awareness to the reality of the global food crisis and ask consumers worldwide to make a commitment to help reduce food waste. On last trading day The Dow Chemical Company (NYSE:DOW) moved up 1.52% to close at $44.76. Its volatility for the week is 5.23% while volatility for the month is 2.99%. DOW's sales growth for past 5 years was -0.10% and its EPS growth for past 5 years was 42.10%. The Dow Chemical Company (NYSE:DOW) monthly performance is -16.76%.Alexander & Baldwin Inc (NYSE:ALEX) and its subsidiary A&B Properties, Inc. completed the land acquisition process to set up Kamehameha Schools’ “The Collection” condominium project. Accordingly, the company said that the construction will begin very soon and likely to complete the construction process by the end of 2016. On last trading day Alexander & Baldwin, Inc. (NYSE:ALEX) moved up 2.33% to close at $35.55. Its volatility for the week is 3.29% while volatility for the month is 2.67%. ALEX's sales growth for past 5 years was -2.50% and its EPS growth for past 5 years was 0.60%. Alexander & Baldwin, Inc. (NYSE:ALEX) monthly performance is -10.16%.Arctic Cat Inc. (NASDAQ:ACAT) announced today that it will webcast its fiscal 2015 second quarter conference call on Thursday, October 23, 2014, at 10:30 a.m. CT (11:30 a.m. ET). The company will release results for its second quarter ended September 30, 2014, before the stock market opens that day. Arctic Cat Inc. (NASDAQ:ACAT) has 1.50% insider ownership while its institutional ownership stands at 92.40%. In last trading activity company's stock closed at $34.10.BRF SA (NASDAQ:BRFS) last posted its quarterly earnings results on Monday, August 4th. The company reported $0.14 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.20 by $0.06. Analysts expect that BRF SA will post $1.89 EPS for the current fiscal year. On Thursday shares of BRF S.A. (NYSE:BRFS) closed at $23.95. Company's sales growth for last 5 years was 21.80% and EPS growth for next 5 years is recorded as 39.59%.
Discover Hidden Gems
Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.
